Alnylam Pharmaceuticals, Inc.
$38.07B- Market cap
- $35.61B
- Debt
- +$4.12B
- Cash
- −$1.66B
Capital structure 90% equity / 10% debt · EV / Revenue 10.25x · EV / EBITDA 63.81x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ALNY · current priceP/E 114.21x
$266.11Latest market snapshot
Implied fair value · at SSNC's multiple
$61.8776.7% below market
2.33 ALNY EPS (TTM)×26.56x SSNC P/E=$61.87
Market $266.11Implied $61.87
SSNC · current priceP/E 26.56x
$83.65Latest market snapshot
Implied fair value · at ALNY's multiple
$359.76330.1% above market
3.15 SSNC EPS (TTM)×114.21x ALNY P/E=$359.76
Market $83.65Implied $359.76